Ss Pharmalabs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 260.03%
- Ebitda 418.77%
- Net Worth 64.21%
- Total Assets 92.11%
About Ss Pharmalabs
Ss Pharmalabs Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 June 2015 (Nine years and seven months 22 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satya Batchu, Srujan Mantena, and Satish Nadimpalli serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73100TG2015PTC099429
-
Company No.
099429
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jun 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Ss Pharmalabs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satya Batchu
|
Additional Director | 15-Jul-2023 | Current |
|
Srujan Mantena
|
Director | 15-Jul-2023 | Current |
|
Satish Nadimpalli
|
Director | 15-Jul-2023 | Current |
Financial Performance of Ss Pharmalabs.
Ss Pharmalabs Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 260.03% increase in profit. The company's net worth Soared by an impressive increase of 64.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ss Pharmalabs?
In 2017, Ss Pharmalabs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Eighthwave Entertainment Private LimitedSatya Batchu is a mutual person
-
Remedium Laboratories Private Limited
Srujan Mantena is a mutual person
-
Alapati Aqua Feeds & Needs Llp
Satish Nadimpalli is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ss Pharmalabs?
Unlock and access historical data on people associated with Ss Pharmalabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ss Pharmalabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ss Pharmalabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
